The genus Mycobacterium comprises more than 70 species, some of which are pathogenic or potentially pathogenic to humans and animals, and some of which are saprobes. Human infections are mainly caused by slowly growing mycobacteria such as Mycobacterium tuberculosis, M. avium complex (MAC), and M. kansasii. Recently, reports of infections due to mycobacteria other than M. tuberculosis complex (MOTT) have been increasing. Because of their clinical importance, in terms of strategies for treatment and the epidemiological implications, the rapid differentiation of causative mycobacteria is important. However, isolation and identification procedures usually require several weeks.
Various PCR-mediated methods had been applied for the rapid detection and identification (or differentiation) of mycobacterial species. Among these different methods PCR-restriction analysis (PRA) is preferred, as a simple and cost-effective method that does not involve radioisotopes. It has been applied to several genes, such as 16S ribosomal DNA (rDNA) (6, 9, 10, 33) , hsp65 (2, 4, 8, 18, 19, 22, 28, 30, 31) , and dnaJ (29) , for the rapid differentiation of closely related clinical isolates, such as Mycobacterium avium subsp. avium and Mycobacterium avium subsp. paratuberculosis (8) , and subspecies of M. kansasii (18) . Previously we reported that comparative sequence analysis of the RNA polymerase gene (rpoB) DNA (342 bp), encompassing the region related to rifampin resistance (Rif r ) in M. tuberculosis, is useful for the identification of mycobacterial species (12) . The present study demonstrates that the same region can be directly used for the differential identification of mycobacteria in sputa and culture isolates. PRA of amplified rpoB DNA can differentiate the two naturally divided mycobacterial groups (rapidly growing and slowly growing mycobacteria) and can distinguish M. tuberculosis from MOTT. According to the identification scheme established in this study, most of the human pathogens of MOTT can be differentiated.
methods listed in Table 1 by KIT. Results obtained from cultures were compared to the results of rpoB PRA (HindII) and IS6110 PCR by blind testing.
Preparation of DNA. Mycobacterial DNAs from the cultures and sediments of sputa were prepared by the method previously described (12) . A loopful of culture of each mycobacterium or sediment was suspended with 200 l of TEN buffer (10 mM Tris-HCl, 1 mM EDTA, 100 mM NaCl [pH 8.0]), placed in a 2.0-ml screw-cap microcentrifuge tube filled with 100 l (packed volume) of glass beads (diameter, 0.1 mm; Biospec Products, Bartlesville, Okla.) and 100 l of phenol-chloroform-isopropyl alcohol (50:49:1). To disrupt the mycobacteria, the tube was oscillated on a Mini-Bead beater (Biospec Products) for 1 min, and to separate phases, the tube was centrifuged (at 12,000 ϫ g for 5 min). After the aqueous phase was transferred into another clean tube, 10 l of 3 M sodium acetate and 250 l of ice-cold ethanol were added; to enable the DNA to precipitate, the mixture was kept at Ϫ20°C for 10 min. The DNA pellet was then washed with 70% ethanol, dissolved in 60 l of TE buffer (10 mM Tris-HCl-1 mM EDTA [pH 8.0]) and used as a template for PCR. DNAs from sputa were prepared as above and dissolved in 60 l of TE buffer (pH 8.0).
Amplification of rpoB and IS6110 DNA. A set of mycobacterium-specific primers (MF and MR) which had been used for the sequence analysis of rpoB DNA (342 bp) (12) was also used in this study. Template DNA (50 ng for the culture and 5 to 10 l for the sputa) and 20 pmol of each primer were added to a PCR mixture tube (AccuPower PCR PreMix; Bioneer, Choongbuk, Korea) which contained 1 U of Taq DNA polymerase, 250 M each deoxynucleoside triphosphate, 50 mM Tris-HCl (pH 8.3), 40 mM KCl, 1.5 mM MgCl 2 , and gel loading dye, and the volume was adjusted to 20 l with distilled water. The reaction mixture was subjected to 30 cycles of amplification (30 s at 95°C, 30 s at 60°C, and 45 s at 72°C) followed by a 5-min extension at 72°C (Thermocycler model 9600; Perkin-Elmer Cetus). M. tuberculosis IS6110 DNAs (536 bp) (32) were separately amplified using an IS6110 kit (catalog no. N5811; Bioneer).
Restriction analysis. Enzyme restriction sites for the sizing of DNA fragments on each of the rpoB sequences of mycobacteria (GenBank accession no. AF057449 to AF057493) were generated by MapDraw, version 3.14 (DNASTAR, Madison, Wis.). Restriction enzymes which produced the most discernible fragments between clusters or strains were selected. Ten microliters of the amplified PCR products was transferred to a fresh microcentrifuge tube and digested with restriction enzymes, according to the supplier's instructions. Following digestion, the mixtures were electrophoresed on a 3% agarose gel (at 100 V for 25 min). DNA bands were visualized by ethidium bromide staining and photographed. The results obtained from the analysis of MAC and M. kansasii isolates were compared with those of DT1-DT6 PCR (5) and PRA (BstEII and HaeIII) of the hsp65 gene (2, 4), respectively.
Nucleotide sequencing. The rpoB DNA sequences for the five reference strains of M. kansasii (subspecies II to VI) and clinical isolates were directly determined as previously described (12) . A 373A automatic sequencer and a BigDye Terminator Cycle Sequencing kit (Perkin-Elmer Applied Biosystems, Warrington, United Kingdom) were used. For the sequencing reaction, 60 ng of PCR-amplified DNA, 3.2 pmol of either the forward or the reverse primer, and 8 l of BigDye Terminator RR mix (Perkin-Elmer Applied Biosystems; catalog no. 4303153) were mixed, and made up to 20 l with distilled water. The reaction was run with 5% (vol/vol) dimethyl sulfoxide for 30 cycles of 15 s at 95°C, 10 s at 50°C, and 4 min at 60°C. The sequences determined were aligned by using the multiple alignment algorithm in the MegAlign package (Windows, version 3.12e; DNASTAR).
Nucleotide sequence accession numbers. The rpoB sequences of five M. kansasii subspecies (II to VI) were deposited in GenBank (accession no. AF173084 to AF173088).
RESULTS
Restriction enzyme sites. The nucleotide sequences of 49 rpoB DNAs were compared by computer-aided analysis. Four useful restriction enzyme sites (HaeIII, HindII, MvaI, and AccII), which produced the most discernible fragments among the tested mycobacterial strains, were selected.
Differentiation of rapidly growing mycobacteria from slowly growing mycobacteria. Mycobacteria belonging to the natural division of rapidly and slowly growing groups were differentiated by the PRA patterns of HaeIII. All of the rapidly growing mycobacteria had G 467 L 468 encoded by GGCCT(G/C) (12) . HaeIII specifically cleaves the rpoB DNAs of rapidly growing mycobacteria, yielding a 61-bp DNA fragment, but does not cleave those of slowly growing mycobacteria. In addition to the 61-bp fragment, another useful marker DNA fragment for rapidly growing mycobacteria upon HaeIII digestion was the 201-bp (or 202-bp) fragment. Most rapidly growing mycobacteria produced the 201/202 bp fragment except M. abscessus and M. fallax (168 bp) and M. chitae (146 bp). Thus, M. abscessus, formerly Mycobacterium chelonae subsp. abscessus, was easily distinguished from M. chelonae and M. fortuitum upon HaeIII digestion (Fig. 1) . Nineteen clinical isolates (11 strains of M. fortuitum and 8 strains of M. chelonae) were confirmed as rapidly growing mycobacteria by PRA of the rpoB DNA. Interestingly, eight strains of M. chelonae complex which had been identified by culture were identified as M. abscessus by PRA of rpoB (HaeIII and AccII), yielding characteristic bands (Table 2) . Furthermore, HaeIII was also useful for distinguish- (12) . Thus, two fragments (232 and 110 bp) were generated from the DNAs of M. tuberculosis complex by HindII, while the MOTT type strains were not cleaved (342 bp) (Fig. 2 ). When this procedure was applied to 134 strains of M. tuberculosis isolates (104 rifampin-susceptible and 30 rifampinresistant strains), they were easily identified (Table 3) , showing characteristic PRA patterns (data not shown).
PRA of rpoB DNA (HindII) and IS6110 PCR were directly applied to 50 sputa and 3 BAL samples, and these results were compared to the results of culture (Table 4) . Nothing was amplified from the culture-negative sputa, which were also smear negative for acid-fast bacilli (AFB). However, rpoB DNAs (342 bp) were amplified from the three smear-positive sputa identified as MOTT by culture. rpoB PRA was compared with the IS6110 PCR for the ability to detect the most common pathogen, M. tuberculosis. The sensitivity of rpoB PRA for detection and identification of M. tuberculosis (93.2%) was slightly lower than that of IS6110 PCR (97.7%). This discrepancy possibly originates from the different copy numbers of rpoB and IS6110. However, it should be noted that the existence of MOTT in the three sputum samples was revealed by rpoB PRA (HindII) (Fig. 3A, lanes 9 , 10, and 11), while it was not detected by IS6110 PCR (Fig. 3B, lanes 9, 10, and 11 ). Both methods specifically detected M. tuberculosis. M. tuberculosis was also detected and cultivated from the three BAL samples. Differentiation of M. kansasii subspecies and M. gastri. The rpoB DNA sequences of five subspecies of M. kansasii (subspecies II to VI) were determined in this study and deposited in GenBank (accession no. AF173084 to AF173088). There were marked variations (90.5 to 98.4% similarity) in the rpoB sequences of six type strains. Subspecies VI of M. kansasii showed low levels of similarity with the other five subspecies (90.5 to 93.1%). However, it was clustered with five other subspecies and M. gastri in the phylogenetic tree constructed by either the neighborhood joining method or the UPGMA method (data not shown). M. gastri, with a 16S rDNA sequence identical with subspecies I, IV, and V, was most similar to subspecies IV with respect to its rpoB sequence (95.8% similarity).
Differentiation of MOTT.
PRA was applied on the basis of these rpoB sequences from six type strains of subspecies. Although subspecies I of M. kansasii was simply differentiated from M. gastri by HaeIII digestion, MvaI and AccII could distinguish the six subspecies of M. kansasii and M. gastri (Table 2 and Fig. 4 ). This procedure was also applied to 47 clinical isolates of M. kansasii. All strains showed identically one of the fragment polymorphisms of subspecies I (45 strains) or II (2 strains) ( Table 3 ). This result was concordant with those of the sequence analysis and PRA of hsp65 (data not shown). The rpoB sequences of two subspecies II strains were identical, and sequence variations among the wild-type strains were less than 0.6%.
Based on the above results, we constructed a scheme for the differential identification of mycobacteria, including almost all of the major human pathogenic species, by rpoB PRA (Fig. 5) .
DISCUSSION
The most common mycobacterial infection in the world is caused by M. tuberculosis. There are also increasing reports of nontuberculous mycobacterial infection not only in the immunocompromised but also in immunocompetent hosts (25, 27) . Among those species that are currently recognized, slow- (30, 31) . It also allowed the elucidation of genetic heterogeneity of many M. kansasii strains by grouping them into five subspecies (4, 18, 31) . However, although the use of the BACTEC system reduced the culturing period, all reports published to date have characterized only the cultured mycobacteria.
In this study, we developed a PRA method using rpoB DNA (342 bp), which comprises the region related to rifampin resistance (Rif r ) in M. tuberculosis. This DNA was previously used for the identification of mycobacteria and the determination of the rifampin susceptibility of M. tuberculosis by sequence analysis (12) . Compared to the other methods PRA of rpoB has unique characteristics, which are practical enough for routine use in the clinical laboratory. First of all, it can not only detect mycobacteria but also determine their natures early in the laboratory process, and it proved to be very useful for identifying rapidly growing mycobacteria and M. tuberculosis. The growth of mycobacteria could be predicted by the PRA of rpoB as by the sequence analysis (12) . According to the deduced amino acid sequences, only the M. terrae complex had the marker amino acid (underlined) for rapidly growing my- Some of the rapidly growing mycobacteria were cultivated from skin biopsy specimens, but unfortunately the biopsy materials were not available. However, considering that only a few members of the rapidly growing mycobacteria cause human infections, PRA of rpoB could be applied directly to biopsy materials as with sputa and BAL specimens. Second, the differentiation of M. tuberculosis and MOTT could be performed on sputa as well as on primary cultures. Thus, the rapid detection and identification of M. tuberculosis or MOTT should provide a prompt differential diagnosis and settle proper management issues depending on the diagnosis. By testing sputa and BAL specimens, we were able to demonstrate the existence of mycobacteria and to identify the mycobacteria detected. Identification of M. tuberculosis in sputa proved to be very useful. For the specific detection of M. tuberculosis, several genes had been used. Of these, IS6110, a multicopy gene in M. tuberculosis, has been most widely used (20) . Although several cases of false-positive results due to amplification from MOTT (11, 15, 16) and false-negative results due to the absence of IS6110 in certain strains of M. tuberculosis had been reported (35) , M. tuberculosis is efficiently detected by the amplification of IS6110 (32) . The sensitivity of IS6110 PCR for the detection of M. tuberculosis in sputa was slightly higher than that of rpoB PRA in this study. This was possibly due to the different copy numbers of rpoB and IS6110. However, it is noteworthy that the existence of MOTT in sputa was revealed not by IS6110 PCR but by PRA of rpoB (HindII). Because IS6110 PCR can detect only M. tuberculosis, MOTT was not detected in sputa (Fig. 3) . Considering the increasing incidence of MOTT infection, the detection of MOTT and its differentiation from M. tuberculosis should be of value. So far, of the bacteria which reside in the respiratory tract, only M. tuberculosis is known to have a HindII restriction site in the 342-bp region.
While this report was being prepared, a method using rpoB DNA was reported (14) . However, it was not based on the rpoB sequences of MOTT and nonmycobacteria. Thus, the investigators had to use only the culture isolates and could not apply PRA to sputa or other primary clinical specimens. The target rpoB DNA differs from ours and does not comprise the Rif r region. The target region we chose has very important information on the rifampin resistance of M. tuberculosis and other naturally rifampin resistant bacteria. Thus, the region can be used for many purposes. Because HindII specifically cleaves the PCR products from M. tuberculosis in sputa, the cleaved fragments of rpoB DNA could be directly sequenced to detect the mutations related to rifampin resistance (data not shown). On occasion, the undigested DNA could be used for MOTT identification. Therefore, we suggest that it would be very (7, 13, 21) , M. kansasii has been increasingly reported to cause infection among patients infected with human immunodeficiency virus (3). Molecular biology methods are also feasible for the rapid identification of M. kansasii. However, such methods are not simple because of the genetic heterogeneity of the species (1, 4, 34) and the identical 16S rDNA sequences of M. kansasii and M. gastri (24) . The existence of a genetic subspecies of M. kansasii was suggested by information on 16S rDNA (26) , the hsp65 gene (4, 18) , and the spacer region between the 16S-23S rRNA genes (2) . In addition, several strains of M. kansasii have recently been proposed to constitute M. kansasii subspecies VI (23) . This report also showed that subspecies I, IV, and V have the same 16S rDNA sequences as M. gastri; for this reason the authors recommended sequencing the hsp65 gene or spacer or performing classical tests to distinguish these species. However, all reference strains and clinical isolates were simply identified by PRA of rpoB. Not only do the results of rpoB PRA correspond with those for the hsp65 gene, but they are also concordant with the fact that M. kansasii subspecies I is the most common human isolate (2) . Unfortunately, isolates of the other subspecies were not available.
Results reaffirming the analytical advantages of rpoB DNA have been demonstrated. Not only can rpoB PRA be applied to culture isolates, but it is also applicable directly to sputa. Its use on sputa will save time and expense. Thus, this technique is suggested as a simple and useful method for the rapid detection and simultaneous identification of pathogenic mycobacteria in primary clinical specimens or for the identification of culture isolates.
